ESTA
Undervalued by 11.4% based on the discounted cash flow analysis.
Market cap | $1.33 Billion |
---|---|
Enterprise Value | $1.48 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-3.07 |
Beta | 0.0 |
Outstanding Shares | 27,459,680 |
Avg 30 Day Volume | 326,334 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -16.98 |
---|---|
PEG | -32.99 |
Price to Sales | 8.44 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 8.99 |
Enterprise Value to EBIT | -22.83 |
Enterprise Value to Net Income | -19 |
Total Debt to Enterprise | 0.13 |
Debt to Equity | 10.41 |
No data
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...